Bioequivalence of domestic and imported Cefdinir Granule in healthy volunteers
Hong-na ZHAO,Man LIU,Xiao-lin WANG,Jing-yi MA,Li-na ZHANG,Min LIU,Dan ZHANG,Yang TONG,Hui-chen LIU
DOI: https://doi.org/10.7501/j.issn.1674-5515.2015.10.003
2015-01-01
Abstract:ObjectiveTo develop a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of cefdinir in human plasma and evaluate the bioequivalence of its two granules.MethodsA single oral dose of 100 mg cefdinir test and reference granules were given to 24 healthy male volunteers in a randomized, two-way crossway study. The concentrations of cefdinir in plasma were determined by LC-MS/MS, and the pharmacokinetic parameters were calculated by WinNonlin 6.3 Software, and the bioequivalence of the two preparations was evaluated.ResultsThe linear range for determining cefdinir in plasma samples was 10.0 — 2000 ng/mL(r= 0.999 7), with the lower limit of quantification (LLOQ) of 10.0 ng/mL. The intra- and inter-batch relative standard deviation (RSD) was lower than 6.0%, and relative error (RE) was within ± 4.0%. Degradation degree of cefdinir in human plasma was increased under the room temperature storage with the extension of storage time. The main pharmacokinetic parameters of test and reference preparations were as follows: AUC0-t were (6238.22 ± 1993.74) and (6331.35 ± 1850.42) ng·h/mL; AUC0-∞ were (6 343.68 ± 2070.73) and (6429.76 ± 1901.33) ng·h/mL;Cmax were (1290 ± 391) and (1330 ± 384) ng/mL;tmax were 2.50 (2.00 — 4.50) h and 2.50 (2.00 — 3.50) h;t1/2 were (1.61 ± 0.17) and (1.61 ± 0.17) h, respectively. The geometric mean ratios (GMRs) for AUC0-t, AUC0-∞, andCmax were 97.88% (90% CI, 91.75% — 104.42%), 97.95% (90% CI, 91.76% — 104.56%) and 96.75% (90% CI, 90.43% — 103.52%), respectively.ConclusionThe established method is rapid, sensitive, accurate, selective, reliable, and sufficient for the determination of cefdinir in human plasma, andthe two preparations are bioequivalent.